Overview

BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects

Status:
Completed
Trial end date:
2017-02-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to collect data to help researchers better understand the various causes of obesity, which may lead to the development of new obesity treatment options.
Phase:
Phase 1
Details
Lead Sponsor:
Translational Research Institute for Metabolism and Diabetes, Florida
Collaborator:
Sanford-Burnham Medical Research Institute
Treatments:
Natriuretic Peptide, Brain